Masjedi et al. (2020) utilized TMC NPs conjugated with HA for the co-delivery of siRNAs targeting interleukin 6 (IL6) and the oncogenic transcription factor STAT3, both crucial in cancer progression. This evidence concerns the gene IL6 and cancer.